Home » Topics » Regulatory

Regulatory
RSS

Therapy of psoriasis with anti-TNF-alpha antibodies

July 19, 2001

Baxter receives EMEA approval for Ceprotin

July 19, 2001

Shorter treatment regimen for Valtrex approved by FDA

July 19, 2001

Immunex seeks FDA approval of Enbrel for psoriatic arthritis

July 18, 2001

Treatment of mild cognitive impairment with glucocorticoid receptor antagonists

July 17, 2001

New Photofrin indication filed with Canadian authorities

July 16, 2001

3M seeks additional FDA approval of QVAR

July 16, 2001

SciClone's Zadaxin receives expanded approval in Mexico

July 12, 2001

Promising phase III trial results reported with Leuprogel three-month depot

July 11, 2001

WHI-P131 useful for preventing colorectal cancer

July 11, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...